Hypothalamic Inflammaging: A Central Driver Of Type 2 Diabetes Mellitus And Metabolic Disease In Aging
As we age, our bodies often experience a subtle, persistent inflammation, sometimes called “inflammaging.” This chronic, low-level inflammation can have far-reaching effects, and new research highlights its significant role in the brain, specifically in a crucial area called the hypothalamus. The hypothalamus acts as the body’s control center for energy balance, appetite, and how our bodies handle sugar (glucose).
This research suggests that as we get older, the support cells in the hypothalamus, known as glial cells (including microglia and astrocytes), start to change. They become less effective at their normal jobs and begin to release more inflammatory signals. This creates a disruptive environment in the hypothalamus, impairing the ability of nerve cells to properly sense glucose, regulate energy, and respond to hormones like insulin. When these vital brain circuits are disrupted, it can lead to widespread problems throughout the body, contributing to insulin resistance and the progression of conditions like type 2 diabetes.
Understanding this connection between brain aging and metabolic health opens up exciting new possibilities for treatment. The findings suggest that by targeting this age-related inflammation in the hypothalamus, we might be able to prevent or even treat age-associated metabolic disorders. Some existing medications for diabetes already show promise in reducing this inflammation, and newer strategies are being explored to restore the hypothalamus to a healthier state.
Source: link to paper